METABOLIC DYSFUNCTION-ASSOCIATED LIVER DISEASE

This adverse event was reported 207 times

These drugs are most commonly taken by patients reporting METABOLIC DYSFUNCTION-ASSOCIATED LIVER DISEASE:

# Drug Count
0 METHOTREXATE SODIUM 26
1 METHOTREXATE 21
2 RITUXIMAB 17
3 ALEMTUZUMAB 15
4 FINGOLIMOD 15
5 FINGOLIMOD HCL 15
6 FINGOLIMOD HYDROCHLORIDE 15
7 ACETAMINOPHEN 14
8 ERGOCALCIFEROL 14
9 METFORMIN 13
See all common drugs associated with METABOLIC DYSFUNCTION-ASSOCIATED LIVER DISEASE

METABOLIC DYSFUNCTION-ASSOCIATED LIVER DISEASE is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 HALOBETASOL PROPIONATE AND TAZAROTENE 1 0.0051
1 FINGOLIMOD HYDROCHLORIDE 15 0.0029
2 RESMETIROM 3 0.0013
3 INFLIXIMAB-DYYB 4 0.0012
4 PROBENECID 1 0.0008
5 TAZAROTENE 1 0.0008
6 NISOLDIPINE 1 0.0008
7 PILOCARPINE HYDROCHLORIDE OPHTHALMIC SOLUTION 1 0.0008
8 AZATHIOPRINE SODIUM 2 0.0008
9 ALEMTUZUMAB 15 0.0008
See all drugs enriched for association with METABOLIC DYSFUNCTION-ASSOCIATED LIVER DISEASE